[1] |
SUN ZR, YANG WM. Neurology[M]. Beijing: People's Medical Publishing House, 2016.
孙忠人, 杨文明. 神经病学[M]. 北京: 人民卫生出版社, 2016.
|
[2] |
CZŁONKOWSKA A, LITWIN T, DUSEK P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4(1): 21. DOI: 10.1038/s41572-018-0018-3.
|
[3] |
XU CC, DONG JJ, CHENG N, et al. Effects of Gantou decoction serum on ATP7b protein subcellular localization and functional expression in Wilson disease model tx mice[J]. Chin J Tradit Chin Med Pharm, 2017, 32(1): 250-253. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201701069.htm
徐陈陈, 董健健, 程楠, 等. 中药肝豆汤含药血清对Wilson病模型TX小鼠肝细胞内ATP7b蛋白亚细胞定位和功能表达的影响[J]. 中华中医药杂志, 2017, 32(1): 250-253. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201701069.htm
|
[4] |
ZHAO W, CHENG N, HAN YZ. Research progress of Wilson's disease animal model[J]. Anhui Med J, 2014, 35(11): 1611-1614. DOI: 10.3969/j.issn.1000-0399.2014.11.046.
赵雯, 程楠, 韩咏竹. Wilson病的动物模型研究进展[J]. 安徽医学, 2014, 35(11): 1611-1614. DOI: 10.3969/j.issn.1000-0399.2014.11.046.
|
[5] |
REED E, LUTSENKO S, BANDMANN O. Animal models of Wilson disease[J]. J Neurochem, 2018, 146(4): 356-373. DOI: 10.1111/jnc.14323.
|
[6] |
XIA M, SUN YH, WANG M, et al. Research progress of common animal models of primary hepatocellularcarcinoma[J]. J Clin Hepatol, 2021, 37(8): 1938-1942. DOI: 10.3969/j.issn.1001-5256.2021.08.042.
夏猛, 孙玉浩, 王萌, 等. 原发性肝癌常见动物模型的研究进展[J]. 临床肝胆病杂志, 2021, 37(8): 1938-1942. DOI: 10.3969/j.issn.1001-5256.2021.08.042.
|
[7] |
RAUCH H. Toxic milk, a new mutation affecting cooper metabolism in the mouse[J]. J Hered, 1983, 74(3): 141-144. DOI: 10.1093/oxfordjournals.jhered.a109751.
|
[8] |
CHEN X, WANG CH, FENG YQ, et al. Experimental study on copper metabolism and liver damage in TX mice[J]. Chin J Hepatol, 2009, 17(9): 688-690. DOI: 10.3760/cma.j.issn.1007-3418.2009.09.012.
陈曦, 王楚怀, 丰岩清, 等. TX小鼠铜代谢和肝损害的实验研究[J]. 中华肝脏病杂志, 2009, 17(9): 688-690. DOI: 10.3760/cma.j.issn.1007-3418.2009.09.012.
|
[9] |
ZISCHKA H, LICHTMANNEGGER J. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models[J]. Ann N Y Acad Sci, 2014, 1315: 6-15. DOI: 10.1111/nyas.12347.
|
[10] |
HOWELL JM, MERCER JF. The pathology and trace element status of the toxic milk mutant mouse[J]. J Comp Pathol, 1994, 110(1): 37-47. DOI: 10.1016/s0021-9975(08)80268-x.
|
[11] |
ZHOU XX, LI XH, CHEN DB, et al. Injury factors and pathological features of toxic milk mice during different disease stages[J]. Brain Behav, 2019, 9(12): e01459. DOI: 10.1002/brb3.1459.
|
[12] |
MEDICI V, HUSTER D. Animal models of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 57-70. DOI: 10.1016/B978-0-444-63625-6.00006-9.
|
[13] |
JIN S, FANG X, BAO YC, et al. Analysis on the characteristics of wilson's disease with renal damage as the main manifestation[J]. Clin J Tradit Chin Med, 2010, 22(11): 1005-1007. DOI: 10.16448/j.cjtcm.2010.11.032.
金珊, 方向, 鲍远程, 等. 以肾脏损害为主要发病表现的Wilson病特点分析[J]. 中医药临床杂志, 2010, 22(11): 1005-1007. DOI: 10.16448/j.cjtcm.2010.11.032.
|
[14] |
ZHANG YH, LI M, QIN J, et al. Extra-nervous manifestations of hepatolenticular degeneration in children[J]. Clin J Appli Pediatr, 1999, 14(5): 277-278. DOI: 10.3969/j.issn.1003-515X.1999.05.024.
张月华, 李明, 秦炯, 等. 儿童肝豆状核变性的神经系统外表现[J]. 实用儿科临床杂志, 1999, 14(5): 277-278. DOI: 10.3969/j.issn.1003-515X.1999.05.024.
|
[15] |
WU HM, CHEN DQ, ZHENG ZD. Hepatolenticular degeneration with renal damage as the first episode (report of 18 cases)[J]. Pediatr Emerg Med, 2001, 8(3): 175-191. DOI: 10.3760/cma.j.issn.1673-4912.2001.03.031.
吴红梅, 陈大庆, 郑祖德. 以肾脏损害首发的肝豆状核变性(附18例报告)[J]. 小儿急救医学, 2001, 8(3): 175-191. DOI: 10.3760/cma.j.issn.1673-4912.2001.03.031.
|
[16] |
CHEN DB, FENG L, LIN XP, et al. Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice[J]. PLoS One, 2012, 7(5): e37709. DOI: 10.1371/journal.pone.0037709.
|
[17] |
TANG LL, LIU DQ, LI R, et al. Protective effect and mechanism of Gandoufumu decoction on liver fibrosis in TX mice[J]. Chin J Integr Tradit West Med, 2018, 38(12): 1461-1466. DOI: 10.7661/j.cjim.20181023.312.
唐露露, 刘丹青, 李睿, 等. 肝豆扶木汤对TX小鼠肝纤维化的保护作用及机制研究[J]. 中国中西医结合杂志, 2018, 38(12): 1461-1466. DOI: 10.7661/j.cjim.20181023.312.
|
[18] |
ZHANG J, TANG LL, LI LY, et al. Gandouling tablets inhibit excessive mitophagy in toxic milk (TX) model mouse of Wilson disease via Pink1/Parkin pathway[J]. Evid Based Complement Alternat Med, 2020, 2020: 3183714. DOI: 10.1155/2020/3183714.
|
[19] |
BUCK NE, CHEAH DM, ELWOOD NJ, et al. Correction of copper metabolism is not sustained long term in Wilson's disease mice post bone marrow transplantation[J]. Hepatol Int, 2008, 2(1): 72-79. DOI: 10.1007/s12072-007-9039-9.
|
[20] |
CORONADO V, NANJI M, COX DW. The Jackson toxic milk mouse as a model for copper loading[J]. Mamm Genome, 2001, 12(10): 793-795. DOI: 10.1007/s00335-001-3021-y.
|
[21] |
JOŃCZY A, LIPIŃSKI P, OGÓREK M, et al. Functional iron deficiency in toxic milk mutant mice (TX-J) despite high hepatic ferroportin: A critical role of decreased GPI-ceruloplasmin expression in liver macrophages[J]. Metallomics, 2019, 11(6): 1079-1092. DOI: 10.1039/c9mt00035f.
|
[22] |
TERWEL D, LÖSCHMANN YN, SCHMIDT HH, et al. Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease[J]. J Neurochem, 2011, 118(1): 105-112. DOI: 10.1111/j.1471-4159.2011.07278.x.
|
[23] |
PRZYBYŁKOWSKI A, GROMADZKA G, WAWER A, et al. Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease[J]. Neurochem Res, 2013, 38(10): 2037-2045. DOI: 10.1007/s11064-013-1111-3.
|
[24] |
MORDAUNT CE, SHIBATA NM, KIEFFER DA, et al. Epigenetic changes of the thioredoxin system in the TX-J mouse model and in patients with Wilson disease[J]. Hum Mol Genet, 2018, 27(22): 3854-3869. DOI: 10.1093/hmg/ddy262.
|
[25] |
BOARU SG, MERLE U, UERLINGS R, et al. Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry[J]. BMC Neurosci, 2014, 15: 98. DOI: 10.1186/1471-2202-15-98.
|
[26] |
ROYBAL JL, ENDO M, RADU A, et al. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease[J]. Gene Ther, 2012, 19(11): 1085-1094. DOI: 10.1038/gt.2011.186.
|
[27] |
KLEIN D, LICHTANNEGGER J, FINCKH M, et al. Gene expression in the liver of Long-Evanscinnamon rats during the development of hepatitis[J]. Arch Toxicol, 2003, 77(10): 568-575. DOI: 10.1007/s00204-003-0493-4.
|
[28] |
SAMUELE A, MANGIAGALLI A, ARMENTERO MT, et al. Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease[J]. Biochim Biophys Acta, 2005, 1741(3): 325-330. DOI: 10.1016/j.bbadis.2005.06.004.
|
[29] |
STERNLIEB I, QUINTANA N, VOLENBERG I, et al. An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats[J]. Hepatology, 1995, 22(6): 1782-1787.
|
[30] |
LEE BH, KIM JM, HEO SH, et al. Proteomic analysis of the hepatic tissue of Long-Evans Cinnamon (LEC) rats according to the natural course of Wilson disease[J]. Proteomics, 2011, 11(18): 3698-3705. DOI: 10.1002/pmic.201100122.
|
[31] |
ZISCHKA H, LICHTMANNEGGER J, SCHMITT S, et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease[J]. J Clin Invest, 2011, 121(4): 1508-1518. DOI: 10.1172/JCI45401.
|
[32] |
LEVY E, BRUNET S, ALVAREZ F, et al. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease[J]. Life Sci, 2007, 80(16): 1472-1483. DOI: 10.1016/j.lfs.2007.01.017.
|
[33] |
HAYASHI M, FUSE S, ENDOH D, et al. Accumulation of copper induces DNA strand breaks in brain cells of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson Disease[J]. Exp Anim, 2006, 55(5): 419-426. DOI: 10.1538/expanim.55.419.
|
[34] |
TOGASHI Y, LI Y, KANG JH, et al. D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats[J]. Hepatology, 1992, 15(1): 82-87. DOI: 10.1002/hep.1840150116.
|
[35] |
KLEIN D, ARORA U, LICHTMANNEGGER J, et al. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease[J]. J Hepatol, 2004, 40(3): 409-416. DOI: 10.1016/j.jhep.2003.11.034.
|
[36] |
JABER FL, SHARMA Y, GUPTA S. Demonstrating potential of cell therapy for Wilson's disease with the long-evans cinnamon rat model[J]. Methods Mol Biol, 2017, 1506: 161-178. DOI: 10.1007/978-1-4939-6506-9_11.
|
[37] |
CHEN S, SHAO C, DONG T, et al. Transplantation of ATP7B-transduced bone marrow mesenchymal stem cells decreases copper overload in rats[J]. PLoS One, 2014, 9(11): e111425. DOI: 10.1371/journal.pone.0111425.
|
[38] |
AHMED S, DENG J, BORJIGIN J. A new strain of rat for functional analysis of PINA[J]. Brain Res Mol Brain Res, 2005, 137(1-2): 63-69. DOI: 10.1016/j.molbrainres.2005.02.025.
|
[39] |
ZISCHKA H, LICHTMANNEGGER J, SCHMITT S, et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease[J]. J Clin Invest, 2011, 121(4): 1508-1518. DOI: 10.1172/JCI45401.
|
[40] |
LICHTMANNEGGER J, LEITZINGER C, WIMMER R, et al. Methanobactin reverses acute liver failure in a rat model of Wilson disease[J]. J Clin Invest, 2016, 126(7): 2721-2735. DOI: 10.1172/JCI85226.
|
[41] |
FIETEN H, PENNING LC, LEEGWATER PA, et al. New canine models of copper toxicosis: diagnosis, treatment, and genetics[J]. Ann N Y Acad Sci, 2014, 1314: 42-48. DOI: 10.1111/nyas.12442.
|
[42] |
HAYWOOD S, VAILLANT C. Overexpression of copper transporter CTR1 in the brain barrier of North Ronaldsay sheep: Implications for the study of neurodegenerative disease[J]. J Comp Pathol, 2014, 150(2-3): 216-224. DOI: 10.1016/j.jcpa.2013.09.002.
|
[43] |
FIETEN H, GILL Y, MARTIN AJ, et al. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: A new canine model for copper-metabolism disorders[J]. Dis Model Mech, 2016, 9(1): 25-38. DOI: 10.1242/dmm.020263.
|
[44] |
HAYWOOD S, MVLLER T, MACKENZIE AM, et al. Copper-induced hepatotoxicosis with hepatic stellate cell activation and severe fibrosis in North Ronaldsay lambs: A model for non- Wilsonian hepatic copper toxicosis of infants[J]. J Comp Pathol, 2004, 130(4): 266-277. DOI: 10.1016/j.jcpa.2003.11.005.
|
[45] |
BATALLER R, BRENNER DA. Hepatic stellate cells as a target for the treatment of liver fibrosis[J]. Semin Liver Dis, 2001, 21(3): 437-451. DOI: 10.1055/s-2001-17558.
|